Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 9, 2009 - Issue 5
Submit an article Journal homepage
144
Views
14
CrossRef citations to date
0
Altmetric
Drug Evaluations

Current situation of zalutumumab

Fernando Rivera Hospital Universitario Marqués de Valdecilla, Department of Medical Oncology, 39008 Santander, Spain +34 942202515; +34 942203362; [email protected]
,
Matilde Salcedo Hospital Universitario Marqués de Valdecilla, Department of Medical Oncology, 39008 Santander, Spain +34 942202515; +34 942203362; [email protected]
,
Noelia Vega Hospital Universitario Marqués de Valdecilla, Department of Medical Oncology, 39008 Santander, Spain +34 942202515; +34 942203362; [email protected]
,
Yolanda Blanco Hospital Universitario Marqués de Valdecilla, Department of Medical Oncology, 39008 Santander, Spain +34 942202515; +34 942203362; [email protected]
&
Carlos López Hospital Universitario Marqués de Valdecilla, Department of Medical Oncology, 39008 Santander, Spain +34 942202515; +34 942203362; [email protected]
Pages 667-674 | Published online: 21 Apr 2009

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Yihui Wen & Jennifer R Grandis. (2015) Emerging drugs for head and neck cancer. Expert Opinion on Emerging Drugs 20:2, pages 313-329.
Read now
Ulrike Schick, Dorothy M Gujral, Tom M Richards, Kevin J Harrington & Christopher M Nutting. (2012) Zalutumumab in head and neck cancer. Expert Opinion on Biological Therapy 12:1, pages 119-125.
Read now
Daniel R. Getts, Meghann T. Getts, Derrick P. McCarthy, Emily ML Chastain & Stephen D. Miller. (2010) Have we overestimated the benefit of human(ized) antibodies?. mAbs 2:6, pages 682-694.
Read now
Shiran Shapira, Victoria Lisiansky, Nadir Arber & Sarah Kraus. (2010) Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins. Expert Opinion on Investigational Drugs 19:sup1, pages S67-S77.
Read now
William Kells Boland & Gwyn Bebb. (2009) Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity. Expert Opinion on Biological Therapy 9:9, pages 1199-1206.
Read now

Articles from other publishers (9)

Miguel Angel Galván Morales, Raúl Barrera Rodríguez, Julio Raúl Santiago Cruz & Luis M. Teran. (2020) Overview of New Treatments with Immunotherapy for Breast Cancer and a Proposal of a Combination Therapy. Molecules 25:23, pages 5686.
Crossref
Amaia Eleonora Maennling, Mehmet Kemal Tur, Marcus Niebert, Torsten Klockenbring, Felix Zeppernick, Stefan Gattenlöhner, Ivo Meinhold-Heerlein & Ahmad Fawzi Hussain. (2019) Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials. Cancers 11:12, pages 1826.
Crossref
Wiktoria Blaszczak, Wojciech Barczak, Anna Wegner, Wojciech Golusinski & Wiktoria Maria Suchorska. (2017) Clinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma. Medical Oncology 34:4.
Crossref
Keith D. Hunter & Robert Bolt. 2012. Biotargets of Cancer in Current Clinical Practice. Biotargets of Cancer in Current Clinical Practice 19 59 .
Martin Goerner, Tanguy Y Seiwert & Holger Sudhoff. (2010) Molecular targeted therapies in head and neck cancer - An update of recent developements -. Head & Neck Oncology 2:1.
Crossref
Igor Vivanco & Ingo K Mellinghoff. (2010) Epidermal growth factor receptor inhibitors in oncology. Current Opinion in Oncology 22:6, pages 573-578.
Crossref
Archontoula Stoffel. (2010) Targeted Therapies for Solid Tumors. BioDrugs 24:5, pages 303-316.
Crossref
Macoura Gadji, Ana-Maria Tsanaclis Crous, David Fortin, Jerry Krcek, Mark Torchia, Sabine Mai, Regen Drouin & Thomas Klonisch. (2009) EGF receptor inhibitors in the treatment of glioblastoma multiform: Old clinical allies and newly emerging therapeutic concepts. European Journal of Pharmacology 625:1-3, pages 23-30.
Crossref
Ningyan Zhang, Brent R. Williams, Ping Lu, Zhiqiang An & Chen-Ni Chin. 2009. Therapeutic Monoclonal Antibodies. Therapeutic Monoclonal Antibodies 711 762 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.